Neutropenia and agranulocytosis in England and Wales: Incidence and risk factors

American Journal of Hematology

Volumn 72, Issue 4, 2003, Pages 248-254

  van Staa, T P ^a,b,c   Boulton, F ^d   Cooper, C ^c   Hagenbeek, A ^e   Inskip, H ^c   Leufkens, Hubert G M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Agranulocytosis; Epidemiology; Incidence; Neutropenia; Risk factor

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; AMOXICILLIN; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIRHEUMATIC AGENT; ANTITHROMBOCYTIC AGENT; ANTITHYROID AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARBIMAZOLE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DIURETIC AGENT; DOSULEPIN; HYPNOTIC SEDATIVE AGENT; IBUPROFEN; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; ENGLAND; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; ODDS RATIO; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; WALES;

EID: 0037381358     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10295     Document Type: Article

References (27)

1. Böttinger LE, Böttinger B. Incidence and cause of aplastic anemia, haemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand 1981;210:475-479.
2. Danielson DA, Douglas SW III, Herzog P, Jick H, Porter JB. Drug-induced blood disorders. J Am Med Assoc 1984;252:3257-3260.
3. Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press; 1991.
4. Rawson NSB, Harding SR, Malcolm E, Lueck L. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol 1998;51:1343-1355.
5. Strom BL, Carson JL, Shinnar R, Snyder ES, Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992;152:1475-1480.
6. Strom BL, Carson JL, Shinnar R, Snyder ES, Shaw M, Lundin FE. Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 1993;153:2119-2121.
7. van der Klauw MM, Goudsmit R, Halie MR, van't Veer MB, Herings RMC, Wilson HP, Stricker BHCh. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 1999;159:369-374.
8. Palva IP, Mustala OO. Drug-induced agranulocytosis with special reference to aminophenazone. Acta Med Scand 1970;187:109-115.
9. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-1099.
10. Jick H, Jick SS, Derby LE. Validation of Information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991;302:766-768.
11. van Staa TP, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994;3:15-21.
12. th edition. New York: McGraw-Hill; 1995. p 815-824.
13. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. New Engl J Med 1993;329:162-167.
14. Arneborn P, Palmblad J. Drug-induced neutropenia in the Stockholm region 1973-1975: frequency and causes. Acta Med Scand 1978;204:283-286.
15. Arneborn P, Palmblad J. Drug-induced neutropenia - a survey for Stockholm 1973-1978. Acta Med Scand 1978;212:289-292.
16. Beauchesne M-F, Shalansky SJ. Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colonystimulating factors. Pharmacotherapy 1999;19:299-305.
17. Chaimongkol B, Nanthachit N, Navarawong V, Siriloiratana P. Drug-induced agranulocytosis. J Med Assoc Thai 1989;72:666-672.
18. D'Antonio D, Iacone A, Fioritoni G, Di Bartolomeo P, Torlontano G. Patterns of infection in 41 patients with idiosyncratic drug-induced agranulocytosis. Ann Hematol 1991;63:84-88.
19. Julia A, Olona M, Bueno J, Revilla E, Rossello J, Petit J, Morey M, Flores A, Font LI, Macia J. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 1991;79:366-371.
20. Lekhakula A, Swasdikul D. Drug-induced agranulocytosis: experience in two university hospitals. J Med Assoc Thai 1991;74:121-130.
21. Mintz U, Shaklai M, Pinkhas J, de Vries A. Drug-induced agranulocytosis. A survey of twenty-three episodes. Rev Roum Med - Med Int 1975;13:205-208.
22. Reizenstein P, Edgardh K. Mortality in agranulocytosis. Lancet 1974;2:293-294.
23. Böttinger LE, Furhoff AK, Holmberg L. Drug-induced blood dyscrasias. Acta Med Scand 1979;205:457-461.
24. van der Klauw MM, Wilson JHP, Stricker BHCh. Drug-associated agranulocytosis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Am J Hematol 1998;57:206-211.
25. Atkin K, Kendall F, Gould D, Freeman H, Lieberman J, O'Sullivan D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatr 1996;169:483-488.
26. Honigfeld G. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis. Psychiatr Serv 1996;47:52-56.
27. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150:621-624.